Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03630809
Title Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
Recruitment Terminated
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute

Her2-receptor positive breast cancer


HER2-pulsed DC1 vaccine

Age Groups:
Covered Countries USA

No variant requirements are available.